Macrolactins: Antitumor Antibiotics as Marine Drug Lead

ISSN: 1875-5348 (Online)
ISSN: 1385-2728 (Print)

Volume 21, 28 Issues, 2017

Download PDF Flyer

Current Organic Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 33rd of 59 in Chemistry, Organic

Submit Abstracts Online Submit Manuscripts Online

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.949
5 - Year: 2.436

Macrolactins: Antitumor Antibiotics as Marine Drug Lead

Current Organic Chemistry, 18(7): 804-811.

Author(s): Tingting Wang, Shan He, Xiaojun Yan and Peng Zhu.

Affiliation: Key Laboratory of Applied Marine Biotechnology of Ministry of Education, Ningbo University, Ningbo 315211, China.


Macrolactins are secondary metabolites mainly from marine microorganisms bearing a unique 24-membered lactone core structure. Since their first occurrence in 1989, they have attracted considerable attention from natural product chemists, organic chemists, and pharmacologists due to their chemical complexity, potent antimicrobial and antitumor activities. Some of them are serving as lead compounds for drug discovery. Although a number of synthetic approaches have been developed, sample supply remains a big issue which precludes further investigation of pharmacological application and mechanisms of action. This review summarizes current knowledge about macrolactins including their chemical diversity, biological activities, synthetic studies, and efficient preparation.


Antibiotic, antitumor, chemical diversity, efficient preparation, macrolactins, synthesis.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 18
Issue Number: 7
First Page: 804
Last Page: 811
Page Count: 8
DOI: 10.2174/138527281807140515144549
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science